Women At Risk
Eligibility Criteria
High Risk Patients are eligible to enroll in the Herbert Irving Cancer Center Research Database if they have one or more of the following:
- A positive history of BRCA 1, 2
- A biopsy-proven history of lobular neoplasia (lobular carcinoma in situ
- A biopsy-proven history of atypical ductal hyperplasia or atypical lobular hyperplasia
Contact
- Research and High-Risk Program Coordinator
- Kitty Silverman
Phone: 212-305-9525
Email: silverk@nyp.org
